SEC Comment Letter for Anterix Inc. (ATEX) (CIK 0001304492) (ATEX) — Jul 7, 2022
Anterix Inc. (ATEX) (CIK 0001304492)
Date: July 7, 2022 · CIK: 0001304492 · Accession: 0000000000-22-007190
AI Filing Summary & Sentiment
File numbers found in text: 333-265930
Letter
United States securities and exchange commission logo July 7, 2022 Gena Ashe Chief Legal Counsel Anterix Inc. 3 Garret Mountain Plaza Suite 401 Woodland Park, New Jersey 07424 Re:Anterix Inc. Registration Statement on Form S-3 Filed June 30, 2022 File No. 333-265930 Dear Ms. Ashe: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Pierce at (202) 551-3887 or Joshua Shainess at (202) 551- 7951 with any questions. Sincerely, Division of Corporation Finance Office of Technology
Show Raw Text
United States securities and exchange commission logo
July 7, 2022
Gena Ashe
Chief Legal Counsel
Anterix Inc.
3 Garret Mountain Plaza
Suite 401
Woodland Park, New Jersey 07424
Re:Anterix Inc.
Registration Statement on Form S-3
Filed June 30, 2022
File No. 333-265930
Dear Ms. Ashe:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Pierce at (202) 551-3887 or Joshua Shainess at (202) 551-
7951 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology